Latest Breaking News On - Guillame van renterghem - Page 1 : comparemela.com

Recce Pharmaceuticals Reports Positive Preclinical Data of

Recce Pharmaceuticals Granted New Patent in Israel for RECCE® Anti-Infectives

SYDNEY, Australia, April 04, 2024 (GLOBE NEWSWIRE) Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), the Company developing a new class of synt.

Recce Pharmaceuticals to Present at the American Society for Clinical Pharmacology & Therapeutics (ASCPT) 2024 Annual Meeting

Recce Pharmaceuticals Establishes Strategic Partnership in South-East Asia to Accelerate Clinical Program

Memorandum of Understanding (MoU) with leading Indonesian biomedical company PT Etana BiotechnologiesMoU aims to facilitate late-stage clinical trials in Indonesia, supporting the Indonesian Government’s access to novel infectious disease medicinesOpportunity to access 10 ASEAN member states1 covering a population of 670 million inhabitantsPatient populations readily available focused on significant unmet medical needs particular to the regionSignificant bilateral initiative supported by the Aus

Recce Pharmaceuticals Secures $8M Placement and Launches $3M Entitlement Offer to Shareholders